Neurology practice during the COVID‐19 outbreak and post‐pandemic era: experiences and challenges

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, is highly infectious and variable, and given that we now understand a large proportion of asymptomatic carriers can be still infectious [1], it is expected that a normalization of epidemic prevention and control measures will be required for a long time worldwide. Our neurology department at Xuanwu Hospital in Beijing is one of the national centers for the research and treatment of neurological disorders in China.